HUMAN FIBROBLAST GROWTH FACTOR 1 (FGF-1) MUTEINS, THEIR DIMERS AND USES
The present invention relates to human fibroblast growth factor (FGF-1) muteins having decreased mitogenicity, dimers of human FGF-1 muteins, as well as such human FGF-1 muteins and dimers of such muteins for use in reducing blood glucose level, particularly for use in the treatment of diabetes. La...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PIECZYKOLAN, JERZY SZCZEPAN ZAKRZEWSKA, MA?GORZATA URSZULA DRZAZGA, EWA OTLEWSKI, JACEK JOZEF BAZYD?O-GUZENDA, KATARZYNA WIECZOREK, MACIEJ JANISZEWSKI, MICHA? MIECZYS?AW KROWARSCH, DANIEL RAFA? CZYREK, ALEKSANDRA ANNA BUDA, PAWE? |
| description | The present invention relates to human fibroblast growth factor (FGF-1) muteins having decreased mitogenicity, dimers of human FGF-1 muteins, as well as such human FGF-1 muteins and dimers of such muteins for use in reducing blood glucose level, particularly for use in the treatment of diabetes.
La présente invention concerne des mutéines du facteur de croissance des fibroblastes 1 (FGF-1) humain ayant une mitogénicité réduite, des dimères de mutéines du FGF-1 humain, ainsi que l'utilisation de ces mutéines du FGF-1 humain et de ces dimères de telles mutéines pour réduire la glycémie, en particulier dans le traitement du diabète. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3219965A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3219965A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3219965A13</originalsourceid><addsrcrecordid>eNrjZHD3CPV19FNw83QK8nfycQwOUXAP8g8P8VBwc3QO8Q9SMFTQcHN30zXUVPANDXH19AvWUQjxcPUMUnDx9HUNClZw9HNRCA12DeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjsZGhpaWZqaOhsZEKAEAI-orTA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HUMAN FIBROBLAST GROWTH FACTOR 1 (FGF-1) MUTEINS, THEIR DIMERS AND USES</title><source>esp@cenet</source><creator>PIECZYKOLAN, JERZY SZCZEPAN ; ZAKRZEWSKA, MA?GORZATA URSZULA ; DRZAZGA, EWA ; OTLEWSKI, JACEK JOZEF ; BAZYD?O-GUZENDA, KATARZYNA ; WIECZOREK, MACIEJ ; JANISZEWSKI, MICHA? MIECZYS?AW ; KROWARSCH, DANIEL RAFA? ; CZYREK, ALEKSANDRA ANNA ; BUDA, PAWE?</creator><creatorcontrib>PIECZYKOLAN, JERZY SZCZEPAN ; ZAKRZEWSKA, MA?GORZATA URSZULA ; DRZAZGA, EWA ; OTLEWSKI, JACEK JOZEF ; BAZYD?O-GUZENDA, KATARZYNA ; WIECZOREK, MACIEJ ; JANISZEWSKI, MICHA? MIECZYS?AW ; KROWARSCH, DANIEL RAFA? ; CZYREK, ALEKSANDRA ANNA ; BUDA, PAWE?</creatorcontrib><description>The present invention relates to human fibroblast growth factor (FGF-1) muteins having decreased mitogenicity, dimers of human FGF-1 muteins, as well as such human FGF-1 muteins and dimers of such muteins for use in reducing blood glucose level, particularly for use in the treatment of diabetes.
La présente invention concerne des mutéines du facteur de croissance des fibroblastes 1 (FGF-1) humain ayant une mitogénicité réduite, des dimères de mutéines du FGF-1 humain, ainsi que l'utilisation de ces mutéines du FGF-1 humain et de ces dimères de telles mutéines pour réduire la glycémie, en particulier dans le traitement du diabète.</description><language>eng ; fre</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221201&DB=EPODOC&CC=CA&NR=3219965A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221201&DB=EPODOC&CC=CA&NR=3219965A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PIECZYKOLAN, JERZY SZCZEPAN</creatorcontrib><creatorcontrib>ZAKRZEWSKA, MA?GORZATA URSZULA</creatorcontrib><creatorcontrib>DRZAZGA, EWA</creatorcontrib><creatorcontrib>OTLEWSKI, JACEK JOZEF</creatorcontrib><creatorcontrib>BAZYD?O-GUZENDA, KATARZYNA</creatorcontrib><creatorcontrib>WIECZOREK, MACIEJ</creatorcontrib><creatorcontrib>JANISZEWSKI, MICHA? MIECZYS?AW</creatorcontrib><creatorcontrib>KROWARSCH, DANIEL RAFA?</creatorcontrib><creatorcontrib>CZYREK, ALEKSANDRA ANNA</creatorcontrib><creatorcontrib>BUDA, PAWE?</creatorcontrib><title>HUMAN FIBROBLAST GROWTH FACTOR 1 (FGF-1) MUTEINS, THEIR DIMERS AND USES</title><description>The present invention relates to human fibroblast growth factor (FGF-1) muteins having decreased mitogenicity, dimers of human FGF-1 muteins, as well as such human FGF-1 muteins and dimers of such muteins for use in reducing blood glucose level, particularly for use in the treatment of diabetes.
La présente invention concerne des mutéines du facteur de croissance des fibroblastes 1 (FGF-1) humain ayant une mitogénicité réduite, des dimères de mutéines du FGF-1 humain, ainsi que l'utilisation de ces mutéines du FGF-1 humain et de ces dimères de telles mutéines pour réduire la glycémie, en particulier dans le traitement du diabète.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD3CPV19FNw83QK8nfycQwOUXAP8g8P8VBwc3QO8Q9SMFTQcHN30zXUVPANDXH19AvWUQjxcPUMUnDx9HUNClZw9HNRCA12DeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjsZGhpaWZqaOhsZEKAEAI-orTA</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>PIECZYKOLAN, JERZY SZCZEPAN</creator><creator>ZAKRZEWSKA, MA?GORZATA URSZULA</creator><creator>DRZAZGA, EWA</creator><creator>OTLEWSKI, JACEK JOZEF</creator><creator>BAZYD?O-GUZENDA, KATARZYNA</creator><creator>WIECZOREK, MACIEJ</creator><creator>JANISZEWSKI, MICHA? MIECZYS?AW</creator><creator>KROWARSCH, DANIEL RAFA?</creator><creator>CZYREK, ALEKSANDRA ANNA</creator><creator>BUDA, PAWE?</creator><scope>EVB</scope></search><sort><creationdate>20221201</creationdate><title>HUMAN FIBROBLAST GROWTH FACTOR 1 (FGF-1) MUTEINS, THEIR DIMERS AND USES</title><author>PIECZYKOLAN, JERZY SZCZEPAN ; ZAKRZEWSKA, MA?GORZATA URSZULA ; DRZAZGA, EWA ; OTLEWSKI, JACEK JOZEF ; BAZYD?O-GUZENDA, KATARZYNA ; WIECZOREK, MACIEJ ; JANISZEWSKI, MICHA? MIECZYS?AW ; KROWARSCH, DANIEL RAFA? ; CZYREK, ALEKSANDRA ANNA ; BUDA, PAWE?</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3219965A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>PIECZYKOLAN, JERZY SZCZEPAN</creatorcontrib><creatorcontrib>ZAKRZEWSKA, MA?GORZATA URSZULA</creatorcontrib><creatorcontrib>DRZAZGA, EWA</creatorcontrib><creatorcontrib>OTLEWSKI, JACEK JOZEF</creatorcontrib><creatorcontrib>BAZYD?O-GUZENDA, KATARZYNA</creatorcontrib><creatorcontrib>WIECZOREK, MACIEJ</creatorcontrib><creatorcontrib>JANISZEWSKI, MICHA? MIECZYS?AW</creatorcontrib><creatorcontrib>KROWARSCH, DANIEL RAFA?</creatorcontrib><creatorcontrib>CZYREK, ALEKSANDRA ANNA</creatorcontrib><creatorcontrib>BUDA, PAWE?</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PIECZYKOLAN, JERZY SZCZEPAN</au><au>ZAKRZEWSKA, MA?GORZATA URSZULA</au><au>DRZAZGA, EWA</au><au>OTLEWSKI, JACEK JOZEF</au><au>BAZYD?O-GUZENDA, KATARZYNA</au><au>WIECZOREK, MACIEJ</au><au>JANISZEWSKI, MICHA? MIECZYS?AW</au><au>KROWARSCH, DANIEL RAFA?</au><au>CZYREK, ALEKSANDRA ANNA</au><au>BUDA, PAWE?</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HUMAN FIBROBLAST GROWTH FACTOR 1 (FGF-1) MUTEINS, THEIR DIMERS AND USES</title><date>2022-12-01</date><risdate>2022</risdate><abstract>The present invention relates to human fibroblast growth factor (FGF-1) muteins having decreased mitogenicity, dimers of human FGF-1 muteins, as well as such human FGF-1 muteins and dimers of such muteins for use in reducing blood glucose level, particularly for use in the treatment of diabetes.
La présente invention concerne des mutéines du facteur de croissance des fibroblastes 1 (FGF-1) humain ayant une mitogénicité réduite, des dimères de mutéines du FGF-1 humain, ainsi que l'utilisation de ces mutéines du FGF-1 humain et de ces dimères de telles mutéines pour réduire la glycémie, en particulier dans le traitement du diabète.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3219965A1 |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | HUMAN FIBROBLAST GROWTH FACTOR 1 (FGF-1) MUTEINS, THEIR DIMERS AND USES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T09%3A22%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PIECZYKOLAN,%20JERZY%20SZCZEPAN&rft.date=2022-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3219965A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |